查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1829233

2025年基於橫向流動免疫檢測（LFIA）的快速檢測全球市場報告

Lateral Flow Immunoassay (LFIA) Based Rapid Test Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，基於側流免疫檢測(LFIA) 的快速檢測市場急劇下滑，從 2024 年的 80.3 億美元下降至 2025 年的 71.7 億美元，複合年成長率為 -10.7%。過去幾年的下滑主要歸因於靈敏度和特異性有限、多重檢測的複雜性、交叉反應問題、儲存和保存期限挑戰以及定量分析能力有限。

預計未來幾年，基於側流免疫檢測(LFIA) 的快速檢測市場將穩定成長，到 2029 年將達到 81.2 億美元，複合年成長率為 3.2%。預測期內的下降可歸因於全球供應鏈中斷、監管挑戰、競爭加劇、替代技術的出現以及與數位健康平台的整合。預測期間的主要趨勢包括：開發用於多次或重複 LFIA 快速檢測及其結果儲存和通訊的先進技術；更重視夥伴關係關係和合作研究；開發家用檢測套組；投資基於人工智慧的疾病篩檢和檢測方法；以及開發患者可輕鬆取得且價格低廉的檢測套組。

側流免疫檢測(LFIA) 快速檢測是一種簡單的技術主導診斷設備，用於檢測人體樣本中是否存在特定目標，例如病原體或生物標記。這些樣本包括各種體液，如尿液、唾液、血液和汗水。

主要方法包括競爭性檢測法、夾心法和多重檢測法。競爭性檢測法特異性檢測採集樣本中是否存在目標物質，例如病原體或生物標記。其應用領域包括感染疾病、懷孕和不孕症評估以及毒理學，並可應用於醫院、診所、診斷實驗室和居家醫療等各種環境。

2025年春季美國關稅的突然上調及其引發的貿易摩擦對醫療設備行業產生了重大影響，尤其對用於診斷影像設備的進口零件、手術用不銹鋼和一次性塑膠製品產生了重大影響。由於醫院和診所抵制漲價，製造商面臨利潤壓力。監管挑戰使情況更加複雜，因為由於關稅而更換供應商通常需要重新認證醫療設備，導致市場進入延遲。為此，企業正在透過雙重採購關鍵零件、增加標準化產品的國內生產以及加快尋找更具成本效益的材料來降低風險。

本研究報告是商業研究公司（The Business Research Company）新報告系列的一部分，該系列提供了基於橫向流動免疫檢測(LFIA) 的快速免疫檢測市場統計數據，包括全球市場規模、各地區佔有率、基於橫向流動免疫檢測分析(LFIA) 的快速檢測市場佔有率的競爭對手、基於橫向流動免疫檢測免疫檢測(LFIA) 的快速檢測市場、市場、市場和細分市場（這份基於橫向流動免疫檢測(LFIA) 的快速檢測市場研究報告透過深入分析產業現況和未來情勢，為您提供全面的觀點。

我們預測未來五年該市場將成長3.2%，較先前預測略有下降1.8%。下降主要源自於美國與其他國家之間關稅的影響。這可能會透過對來自丹麥和巴西等主要地區的單株抗體檢測線和樣品墊片材料徵收關稅直接影響美國，從而導致就地檢驗的可用性降低，並增加傳染病篩檢的成本。由於互惠關稅以及貿易緊張局勢和限制措施加劇對全球經濟和貿易的負面影響，影響可能會更加廣泛。

品管是阻礙側流免疫檢測(LFIA) 快速檢測市場成長的關鍵挑戰。包括工資和技術投資在內的營運成本不斷上升，正在擠壓許多公司的利潤率。例如，2023 年 6 月，美國非營利組織 PLOS 的一份報告強調，市面上的 LFIA 產品並非始終符合高可靠性和特異性標準。一項針對四項 LFIA 檢測的回顧性評估顯示，其診斷效能存在相當大的差異，一些檢測對 IgG 檢測的準確率甚至低至 47%。

由於慢性病的盛行率不斷上升，基於側流免疫檢測(LFIA) 的快速檢測市場預計將持續成長。這些長期健康狀況需要早期發現、就地檢驗和定期監測，而基於 LFIA 的快速檢測能夠快速提供結果並有助於管理慢性病。世界衛生組織 (WHO) 報告稱，非傳染性疾病 (NCD) 每年導致大量死亡，這凸顯了 LFIA 在治療心血管疾病、癌症、慢性呼吸系統疾病和糖尿病等疾病方面的作用。因此，慢性病盛行率的上升推動了市場的發展。

基於側流免疫檢測(LFIA) 的快速檢測市場的主要企業正專注於定量聚合酵素鏈鎖反應(qPCR) 等技術，以提高檢測靈敏度和特異性，加快檢測速度，並擴大可識別的病原體和生物標記的範圍。 qPCR 技術是一種分子生物學技術，用於即時擴增和定量 DNA 或 RNA 序列，從而能夠精確測量基因表現量並檢測各種樣本中的特定病原體。例如，2023 年 11 月，瑞士製藥公司 F. Hoffmann-La Roche 宣布推出 LightCycler PRO 系統。該系統基於羅氏的 qPCR 技術開發，採用黃金標準技術，實現高品質、高精度和高可靠性，這對於準確的患者診斷和有效的臨床決策至關重要。

側流免疫檢測(LFIA) 快速檢測市場的主要企業也在投資綜合健康解決方案，旨在透過改進跨醫療平台的數據共用和協作來提高診斷效率、最佳化工作流程並提供全面的患者照護。綜合健康解決方案包含一個綜合醫療保健系統，該系統連接各種服務、技術和數據，以改善患者照護並簡化營運。例如，2024 年 6 月，羅氏公司 (F. Hoffmann-La Roche AG) 推出了其 Cobas Pro 綜合解決方案的分析單元。 Cobas Pro 系統配備一個每小時最多可處理 1,000 個樣本的樣本供應單元、一個每小時最多可進行 900 次測試的離子選擇電極 (ISE) 以及一個專門用於臨床化學的 Cobas C 503 單元，每小時最多可進行 1,000 次測試。

2023年8月，丹納赫集團以57億美元收購了Abcam，這符合丹納赫強化其生命科學業務的策略。 Abcam是一家專注於基於LFIA的快速檢測的英國生技公司，此次收購預計將提升股東價值，並為員工和客戶帶來卓越的成果。

以橫向流動免疫檢測(LFIA) 為基礎的快速檢測市場的主要企業包括雅培實驗室、F. Hoffmann-La Roche、Quidel Corporation、Becton, Dickinson and Company、丹納赫公司、西門子股份公司、賽默飛世爾科技公司、Bio-Rad Laboratories, Inc.、PerkinElmer Inc.、Hologic, Inc.、UIO,LTEK 股份有限公司Biotechnology、江蘇美多美醫療技術有限公司、Diagnocure、Ubio Biotechnology Systems、Elabscience® Immunoassay Kits、FyoniBio/Glycotope GmbH、Atomo Diagnostics Limited、INDICAL Bioscience、Lionex Gmbh、BIOMED Lgnostator GunchakHdiaostto Ltd、Qiagen NV、默克集團、XPhyto Therapeutics、3a Diagnostics、羅氏控股公司、BATM、Biomaxima、SensDx Vitrosens Biotechnology、Bioeasy Biotechnology、Fujirebio、Immunodiagnostic Systems Holdings PLC、Mesa Biotech Inc、CTK Biotech。

2024年，基於側流免疫檢測(LFIA) 的快速檢測市場最大的地區是北美。亞太地區是全球基於側流免疫檢測(LFIA) 的快速檢測市場的第二大地區。側流免疫檢測(LFIA) 的快速檢測市場報告涵蓋的地區包括亞太地區、西歐、東歐、北美、南美、中東和非洲。

基於橫向流動免疫檢測(LFIA) 的快速檢測市場報告涵蓋的國家有澳洲、巴西、中國、法國、德國、印度、印尼、日本、俄羅斯、韓國、英國、美國、義大利、加拿大和西班牙。

基於側流免疫檢測(LFIA) 的快速檢測市場包括結合墊片、硝酸纖維素膜和吸收墊片的銷售。該市場的數據為出廠價，即商品由製造商或生產者銷售給其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接銷售給最終消費者的價值。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 基於全球橫向流動免疫檢測(LFIA) 的快速檢測：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 最終用途產業分析
  • 全球基於橫向流動免疫檢測(LFIA) 的快速檢測市場：成長率分析
  • 全球基於橫向流動免疫檢測(LFIA) 的快速檢測市場表現：規模與成長，2019-2024 年
  • 全球基於側流免疫檢測(LFIA) 的快速檢測市場預測：規模與成長，2024-2029 年，2034 年
  • 全球基於橫向流動免疫檢測(LFIA) 的快速檢測：總潛在市場 (TAM)

第6章 市場細分

  • 全球基於側流免疫檢測(LFIA) 的快速檢測市場（按技術、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • 競爭分析
  • 夾心試驗
  • 多重檢測分析
  • 全球基於側流免疫檢測(LFIA) 的快速檢測市場（按應用、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • 感染疾病
  • 妊娠和不孕症治療
  • 毒理學
  • 心臟標記和膽固醇檢測
  • 其他
  • 全球基於側流免疫檢測(LFIA) 的快速檢測市場（按最終用戶、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • 醫院診所
  • 診斷實驗室
  • 居家醫療
  • 其他
  • 全球基於側流免疫檢測(LFIA) 的快速檢測市場：競爭性檢測細分市場，按類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 直接競爭試驗
  • 間接競爭試驗
  • 全球基於側流免疫檢測(LFIA) 的快速檢測市場：夾心法細分、類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 一步夾心試驗
  • 兩階段夾心試驗
  • 全球基於側流免疫檢測(LFIA) 的快速檢測市場：多重檢測分析細分，按類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 多分析物檢測
  • 同時偵測各種目標

第7章 區域和國家分析

  • 全球基於橫向流動免疫檢測(LFIA) 的快速檢測市場：按地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球基於橫向流動免疫檢測(LFIA) 的快速檢測市場：國家、績效及預測（2019-2024 年、2024-2029 年、2034 年）

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 基於橫向流動免疫檢測(LFIA) 的快速偵測市場：競爭格局
  • 基於橫向流動免疫檢測（LFIA）的快速檢測市場：公司簡介
    • Abbott Laboratories
    • F. Hoffmann-La Roche
    • Quidel Corporation
    • Becton, Dickinson and Company
    • Danaher Corporation

第31章：其他領先和創新企業

  • Siemens AG
  • Thermo Fisher Scientific Inc.
  • Bio-Rad Laboratories, Inc.
  • PerkinElmer Inc.
  • Hologic, Inc.
  • LTEK Co., Ltd.
  • JOYSBIO BIoTechnology
  • Jiangsu Medomics Medical Technologies
  • Diagnocure
  • Ubio BIoTechnology Systems
  • Elabscience（R）Immunoassay Kits
  • FyoniBio/Glycotope GmbH
  • Atomo Diagnostics Limited
  • INDICAL Bioscience
  • Lionex Gmbh

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第35章：市場潛力大的國家與策略

  • 2029年基於橫向流動免疫檢測（LFIA）的快速檢測市場：提供新機會的國家
  • 2029年基於橫向流動免疫檢測（LFIA）的快速檢測市場：細分市場帶來新機會
  • 2029年基於橫向流動免疫檢測（LFIA）的快速檢測市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r25741u

The rapid test based on Lateral Flow Immunoassay (LFIA) is a straightforward technology-driven diagnostic device employed for detecting the presence of specific targets, such as pathogens or biomarkers, in samples obtained from the human body. These samples encompass various bodily fluids such as urine, saliva, blood, and sweat.

The primary techniques include the competitive assay, sandwich assay, and multiplex detection assay. The competitive assay specifically determines the presence of targets, such as pathogens or biomarkers, within the collected samples. Its applications span infectious diseases, pregnancy and fertility assessments, toxicology, and others, making it applicable in diverse settings such as hospitals, clinics, diagnostic laboratories, home care, and more.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The lateral flow immunoassay (LFIA) based rapid test market research report is one of a series of new reports from The Business Research Company that provides lateral flow immunoassay (LFIA) based rapid test market statistics, including lateral flow immunoassay (LFIA) based rapid test industry global market size, regional shares, competitors with a lateral flow immunoassay (LFIA) based rapid test market share, detailed lateral flow immunoassay (LFIA) based rapid test market segments, market trends and opportunities, and any further data you may need to thrive in the lateral flow immunoassay (LFIA) based rapid test industry. This lateral flow immunoassay (LFIA) based rapid test market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The lateral flow immunoassay (lfia) based rapid test market size has declined steeply in recent years. It will decline from $8.03 billion in 2024 to $7.17 billion in 2025 at a compound annual growth rate (CAGR) of -10.7%. The decline in the historic period can be attributed to limited sensitivity and specificity, complexity of multiplexing, cross-reactivity issues, storage and shelf-life challenges, limited quantitative capability.

The lateral flow immunoassay (lfia) based rapid test market size is expected to see steady growth in the next few years. It will grow to $8.12 billion in 2029 at a compound annual growth rate (CAGR) of 3.2%. The decline in the forecast period can be attributed to global supply chain disruptions, regulatory challenges, increased competition, emergence of alternative technologies, integration with digital health platforms. Major trends in the forecast period include developing advanced technologies for multiple or repetitive LFIA based rapid test and storage/ communication of results, focus on partnerships and collaborations, develop at home test kits, invest in artificial intelligence-based tests for diseases screening and detection, and should develop low-cost test kits for easy access to patients at low cost.

The forecast of 3.2% growth over the next five years reflects a modest reduction of 1.8% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through tariffs on monoclonal antibody test lines and sample pad materials, sourced from key regions such as Denmark and Brazil, which could lead to reduced point-of-care testing availability and higher expenses for infectious disease screening.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Quality control continues to be a significant challenge anticipated to impede the growth of the lateral flow immunoassay (LFIA) rapid test market. Rising operational costs, encompassing salaries and technology investments, have strained profit margins for numerous firms. For example, in June 2023, a report from PLOS, a US-based non-profit organization, highlighted that LFIA products available in the market do not consistently adhere to high standards of reliability and specificity. A retrospective assessment of four LFIA tests indicated considerable variability in diagnostic performance, with some tests demonstrating accuracy rates as low as 47% for IgG detection.

The lateral flow immunoassay (LFIA) based rapid test market is set to experience growth fueled by the increasing prevalence of chronic diseases. These long-term health conditions demand early detection, point-of-care testing, and regular monitoring, with LFIA-based rapid tests offering prompt results and aiding in the management of chronic diseases. The World Health Organization reports a significant number of deaths attributed to non-communicable diseases (NCDs) annually, emphasizing the role of LFIA in addressing conditions such as cardiovascular diseases, cancer, chronic respiratory diseases, and diabetes. The market is thus stimulated by the rising incidence of chronic diseases.

Major companies in the lateral flow immunoassay (LFIA)-based rapid test market are concentrating on technologies like qPCR (quantitative polymerase chain reaction) to improve the sensitivity and specificity of their tests, accelerate detection speed, and broaden the range of pathogens or biomarkers that can be identified. This focus aims to lead to more reliable and accurate diagnostic solutions for various healthcare applications. qPCR technology is a molecular biology method used to amplify and quantify DNA or RNA sequences in real time, allowing for precise measurements of gene expression levels or the detection of specific pathogens in various samples. For example, in November 2023, F. Hoffmann-La Roche AG, a Switzerland-based pharmaceutical company, introduced the LightCycler PRO System. This system builds on Roche's legacy of qPCR technologies, employing gold-standard techniques to ensure high quality, precision, and reliability-capabilities that are vital for accurate patient diagnosis and effective clinical decision-making.

Leading companies in the lateral flow immunoassay (LFIA)-based rapid test market are also investing in Integrated Health Solutions to enhance diagnostic efficiency, optimize workflows, and deliver comprehensive patient care through improved data sharing and collaboration across healthcare platforms. Integrated Health Solutions encompass comprehensive healthcare systems that link various services, technologies, and data to enhance patient care and streamline operations. For instance, in June 2024, F. Hoffmann-La Roche AG launched analytical units for its Cobas Pro integrated solutions. The Cobas Pro system can process up to 1,000 samples per hour with its sample supply unit and features high-speed analytical units capable of conducting up to 900 tests per hour for the ion-selective electrode (ISE) and 1,000 tests per hour for the Cobas C 503 unit, which specializes in clinical chemistry.

In August 2023, Danaher Corporation acquired Abcam plc for $5.7 billion, aligning with Danaher's strategy to bolster its life sciences business. The acquisition of Abcam, a UK-based biotechnology company specializing in LFIA-based rapid tests, is expected to enhance value for shareholders and deliver outstanding results for both the workforce and clients.

Major companies operating in the lateral flow immunoassay (LFIA) based rapid test market include Abbott Laboratories, F. Hoffmann-La Roche, Quidel Corporation, Becton, Dickinson and Company, Danaher Corporation, Siemens AG, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., PerkinElmer Inc., Hologic, Inc., LTEK Co., Ltd., JOYSBIO Biotechnology, Jiangsu Medomics Medical Technologies, Diagnocure, Ubio Biotechnology Systems, Elabscience(R) Immunoassay Kits, FyoniBio / Glycotope GmbH, Atomo Diagnostics Limited, INDICAL Bioscience, Lionex Gmbh, BIOMED Labordiagnostik GmbH, Charles River Laboratories, EKF Diagnostics, Launch Diagnostics, Diagnostic Instruments Ltd, Qiagen N.V., Merck KGaA, XPhyto Therapeutics, 3a Diagnostics, Roche Holding AG, BATM, Biomaxima, SensDx, Vitrosens Biotechnology, Bioeasy Biotechnology, Fujirebio, Immunodiagnostic Systems Holdings PLC, Mesa Biotech Inc, CTK Biotech

North America was the largest region in the lateral flow immunoassay (LFIA) based rapid test market in 2024. Asia-Pacific was the second largest region in the global lateral flow immunoassay (LFIA) based rapid test market. The regions covered in the lateral flow immunoassay (LFIA) based rapid test market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the lateral flow immunoassay (LFIA) based rapid test market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain

Lateral Flow Immunoassay (LFIA) based rapid test market consists of sales of conjugate pads, nitrocellulose membrane and absorbent pad. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Lateral Flow Immunoassay (LFIA) Based Rapid Test Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on lateral flow immunoassay (lfia) based rapid test market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for lateral flow immunoassay (lfia) based rapid test ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The lateral flow immunoassay (lfia) based rapid test market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Technique: Competitive Assay, Sandwich Assay, Multiplex Detection Assay
  • 2) By Application: Infectious Disease, Pregnancy And Fertility, Toxicology, Cardiac Marker And Cholesterol Testing, Other Applications
  • 3) By End-Users: Hospitals And Clinics, Diagnostic Laboratories, Home Care, Other End Users
  • Subsegments:
  • 1) By Competitive Assay: Direct Competitive Assays; Indirect Competitive Assays
  • 2) By Sandwich Assay: Single-step Sandwich Assays; Two-step Sandwich Assays
  • 3) By Multiplex Detection Assay: Multi-analyte Assays; Simultaneous Detection Of Various Targets
  • Companies Mentioned: Abbott Laboratories; F. Hoffmann-La Roche; Quidel Corporation; Becton, Dickinson and Company; Danaher Corporation; Siemens AG; Thermo Fisher Scientific Inc.; Bio-Rad Laboratories, Inc.; PerkinElmer Inc.; Hologic, Inc.; LTEK Co., Ltd.; JOYSBIO Biotechnology; Jiangsu Medomics Medical Technologies; Diagnocure; Ubio Biotechnology Systems; Elabscience(R) Immunoassay Kits; FyoniBio / Glycotope GmbH; Atomo Diagnostics Limited; INDICAL Bioscience; Lionex Gmbh; BIOMED Labordiagnostik GmbH; Charles River Laboratories; EKF Diagnostics; Launch Diagnostics; Diagnostic Instruments Ltd; Qiagen N.V.; Merck KGaA; XPhyto Therapeutics; 3a Diagnostics; Roche Holding AG; BATM; Biomaxima; SensDx; Vitrosens Biotechnology; Bioeasy Biotechnology; Fujirebio; Immunodiagnostic Systems Holdings PLC; Mesa Biotech Inc; CTK Biotech
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Characteristics

3. Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Trends And Strategies

4. Lateral Flow Immunoassay (LFIA) Based Rapid Test Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Growth Rate Analysis
  • 5.4. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Total Addressable Market (TAM)

6. Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Segmentation

  • 6.1. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Competitive Assay
  • Sandwich Assay
  • Multiplex Detection Assay
  • 6.2. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Infectious Disease
  • Pregnancy & Fertility
  • Toxicology
  • Cardiac Marker And Cholesterol Testing
  • Other Applications
  • 6.3. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospital & Clinic
  • Diagnostic Laboratory
  • Home Care
  • Other End Users
  • 6.4. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Sub-Segmentation Of Competitive Assay, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Direct Competitive Assays
  • Indirect Competitive Assays
  • 6.5. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Sub-Segmentation Of Sandwich Assay, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Single-step Sandwich Assays
  • Two-step Sandwich Assays
  • 6.6. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Sub-Segmentation Of Multiplex Detection Assay, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Multi-analyte Assays
  • Simultaneous Detection Of Various Targets

7. Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Regional And Country Analysis

  • 7.1. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 8.1. Asia-Pacific Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 9.1. China Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Overview
  • 9.2. China Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 10.1. India Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 11.1. Japan Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Overview
  • 11.2. Japan Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 12.1. Australia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 13.1. Indonesia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 14.1. South Korea Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Overview
  • 14.2. South Korea Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 15.1. Western Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Overview
  • 15.2. Western Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 16.1. UK Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 17.1. Germany Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 18.1. France Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 19.1. Italy Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 20.1. Spain Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 21.1. Eastern Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Overview
  • 21.2. Eastern Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 22.1. Russia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 23.1. North America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Overview
  • 23.2. North America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 24.1. USA Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Overview
  • 24.2. USA Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 25.1. Canada Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Overview
  • 25.2. Canada Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 26.1. South America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Overview
  • 26.2. South America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 27.1. Brazil Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 28.1. Middle East Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Overview
  • 28.2. Middle East Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 29.1. Africa Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Overview
  • 29.2. Africa Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Competitive Landscape And Company Profiles

  • 30.1. Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Competitive Landscape
  • 30.2. Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Company Profiles
    • 30.2.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. F. Hoffmann-La Roche Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Quidel Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Becton, Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Other Major And Innovative Companies

  • 31.1. Siemens AG
  • 31.2. Thermo Fisher Scientific Inc.
  • 31.3. Bio-Rad Laboratories, Inc.
  • 31.4. PerkinElmer Inc.
  • 31.5. Hologic, Inc.
  • 31.6. LTEK Co., Ltd.
  • 31.7. JOYSBIO Biotechnology
  • 31.8. Jiangsu Medomics Medical Technologies
  • 31.9. Diagnocure
  • 31.10. Ubio Biotechnology Systems
  • 31.11. Elabscience(R) Immunoassay Kits
  • 31.12. FyoniBio / Glycotope GmbH
  • 31.13. Atomo Diagnostics Limited
  • 31.14. INDICAL Bioscience
  • 31.15. Lionex Gmbh

32. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

34. Recent Developments In The Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

35. Lateral Flow Immunoassay (LFIA) Based Rapid Test Market High Potential Countries, Segments and Strategies

  • 35.1 Lateral Flow Immunoassay (LFIA) Based Rapid Test Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Lateral Flow Immunoassay (LFIA) Based Rapid Test Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Lateral Flow Immunoassay (LFIA) Based Rapid Test Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer